Lung Distress

Arsenicum Iodatum, Blatta Orientalis, Bryonia (alba), Carbo Vegetabilis, Eupatorium Perfoliatum, Histaminum Hydrochloricum, Ipecacuanha, Lung Suis, Natrum Sulphuricum, Nitricum Album, Quebracho, Sambucus Nigra, Sticta Pulmonaria, Urtica Urens


Liddell Laboratories
Human Otc Drug
NDC 50845-0242
Lung Distress also known as Arsenicum Iodatum, Blatta Orientalis, Bryonia (alba), Carbo Vegetabilis, Eupatorium Perfoliatum, Histaminum Hydrochloricum, Ipecacuanha, Lung Suis, Natrum Sulphuricum, Nitricum Album, Quebracho, Sambucus Nigra, Sticta Pulmonaria, Urtica Urens is a human otc drug labeled by 'Liddell Laboratories'. National Drug Code (NDC) number for Lung Distress is 50845-0242. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Lung Distress drug includes Activated Charcoal - 12 [hp_X]/mL Arsenic Triiodide - 200 [hp_C]/mL Aspidosperma Quebracho-blanco Bark - 3 [hp_X]/mL Blatta Orientalis - 30 [hp_C]/mL Bryonia Alba Root - 6 [hp_X]/mL Eupatorium Perfoliatum Flowering Top - 6 [hp_X]/mL European Elderberry - 3 [hp_X]/mL Histamine Dihydrochloride - 200 [hp_C]/mL Ipecac - 4 [hp_X]/mL Lobaria Pulmonaria - 200 [hp_C]/mL and more. The currest status of Lung Distress drug is Active.

Drug Information:

Drug NDC: 50845-0242
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Lung Distress
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Arsenicum Iodatum, Blatta Orientalis, Bryonia (alba), Carbo Vegetabilis, Eupatorium Perfoliatum, Histaminum Hydrochloricum, Ipecacuanha, Lung Suis, Natrum Sulphuricum, Nitricum Album, Quebracho, Sambucus Nigra, Sticta Pulmonaria, Urtica Urens
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Liddell Laboratories
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Spray
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ACTIVATED CHARCOAL - 12 [hp_X]/mL
ARSENIC TRIIODIDE - 200 [hp_C]/mL
ASPIDOSPERMA QUEBRACHO-BLANCO BARK - 3 [hp_X]/mL
BLATTA ORIENTALIS - 30 [hp_C]/mL
BRYONIA ALBA ROOT - 6 [hp_X]/mL
EUPATORIUM PERFOLIATUM FLOWERING TOP - 6 [hp_X]/mL
EUROPEAN ELDERBERRY - 3 [hp_X]/mL
HISTAMINE DIHYDROCHLORIDE - 200 [hp_C]/mL
IPECAC - 4 [hp_X]/mL
LOBARIA PULMONARIA - 200 [hp_C]/mL
NITRIC ACID - 200 [hp_C]/mL
SODIUM SULFATE - 30 [hp_C]/mL
SUS SCROFA LUNG - 6 [hp_X]/mL
URTICA URENS - 6 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 15 Oct, 2018
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 02 Jan, 2024
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 10 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Liddell Laboratories
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0363113076967
UPC stands for Universal Product Code.
NUI:N0000185365
N0000175629
N0000184306
N0000185001
M0028968
M0000728
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:2P3VWU3H10
3029988O2T
52B1340190
535787266D
T7J046YI2B
1W0775VX6E
BQY1UBX046
3POA0Q644U
62I3C8233L
D1YM0P5Z2T
411VRN1TV4
0YPR65R21J
7GL3G1COB3
IHN2NQ5OF9
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:Non-Standardized Insect Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:Increased Histamine Release [PE]
Cell-mediated Immunity [PE]
Increased IgG Production [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:Insect Proteins [CS]
Allergens [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:Allergens [CS]
Cell-mediated Immunity [PE]
Increased Histamine Release [PE]
Increased IgG Production [PE]
Insect Proteins [CS]
Non-Standardized Insect Allergenic Extract [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
50845-0242-130 mL in 1 BOTTLE, DROPPER (50845-0242-1)15 Oct, 201802 Jan, 2024No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Uses: may temporarily relieve minor symptoms associated with breathing difficulties: • congestion • coughing • wheezing • tight feeling in the chest** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Product Elements:

Lung distress arsenicum iodatum, blatta orientalis, bryonia (alba), carbo vegetabilis, eupatorium perfoliatum, histaminum hydrochloricum, ipecacuanha, lung suis, natrum sulphuricum, nitricum album, quebracho, sambucus nigra, sticta pulmonaria, urtica urens arsenic triiodide arsenic cation (3+) blatta orientalis blatta orientalis bryonia alba root bryonia alba root activated charcoal activated charcoal eupatorium perfoliatum flowering top eupatorium perfoliatum flowering top histamine dihydrochloride histamine ipecac ipecac sus scrofa lung sus scrofa lung sodium sulfate sodium sulfate anhydrous nitric acid nitric acid aspidosperma quebracho-blanco bark aspidosperma quebracho-blanco bark european elderberry european elderberry lobaria pulmonaria lobaria pulmonaria urtica urens urtica urens water alcohol

Indications and Usage:

Indications: may temporarily relieve minor symptoms associated with breathing difficulties: • congestion • coughing • wheezing • tight feeling in the chest** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Warnings:

Warnings: do not use if you have ever had an allergic reaction to this product or any of its ingredients. stop use and ask a doctor if symptoms persist, worsen or if new symptoms occur. keep out of reach of children. in case of overdose, get medical help or call a poison control center right away. if pregnant or breast-feeding, ask a doctor before using product. other information: store at room temperature. do not use if tamper evident seal around neck of bottle is missing or broken.

Dosage and Administration:

Directions: adults and children over 12: spray twice under the tongue 3 times per day. for severe symptoms, dosage may be taken up to six times the first day. children 12 and under: consult a doctor prior to use.

Package Label Principal Display Panel:

Package label display: oral sprays liddell laboratories est 1994 16 lu lung distress may relieve minor symptoms associated with breathing difficulties: congestion, coughing, wheezing, tight feeling in the chest. homeopathic doctor formulated readily absorbed. safe. no known side effects. easy to use. 1.0 fl oz. (30 ml) lung distress lbl lung distress ctn

Further Questions:

Questions: dist. by: liddell laboratories 201 apple blvd. woodbine, ia 51579 www.liddell.net 1-800-460-7733


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.